Alphatec Spine to Host Technology Day on June 6, 2013 in New York City
09 Mai 2013 - 10:25PM
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of
Alphatec Spine, Inc., a medical device company that designs,
develops, manufactures and markets physician-inspired solutions for
patients with spinal disorders, announced today that the Company
will conduct a Technology Day for investors and analysts on
Thursday, June 6, 2013 from 8:30 AM to 11:30 AM Eastern Time at the
Convene Conference Center (formerly Sentry Centers), which is
located at 730 Third Avenue in NYC.
The agenda will include presentations from Alphatec's senior
management and select spine surgeons, followed by a question and
answer period and product demonstrations. To register for this
event, please RSVP to investor relations prior to May 31, 2013.
Seating is limited.
"We are extremely pleased to showcase our newest products
including our Alphatec Solus® anchored, anterior lumbar interbody
fusion device, our Pegasus™ anchored, anterior cervical interbody
device, our new Zodiac® DVR (Direct Vertebral Rotation) System, and
our expanding portfolio of ILLICO® minimally invasive surgery
systems (MIS), including our ILLICO Multi-Level MIS System," said
Les Cross, Chairman and CEO of Alphatec Spine. "We invite members
of the financial community to attend our event and learn more about
Alphatec Spine's innovations in the spine industry that are helping
to improve patient care in the operating room."
The presentations made by the Company's management at the
Alphatec Spine Technology Day will be webcast live and accessible
through the Company's investor relations website at
www.alphatecspine.com. An archived edition of the presentation will
be available later that day and will be available for at least 30
days afterwards.
About Alphatec Spine
Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec
Holdings, Inc., is a medical device company that designs, develops,
manufactures and markets products and solutions for the treatment
of spinal disorders associated with trauma, congenital deformities,
disease and degeneration. The Company's mission is to combine
innovative, surgeon-inspired solutions that will help improve
outcomes and patient's quality of life, with world-class customer
service. To achieve its mission, the Company strives to
commercialize new and innovative devices and technologies,
including improved minimally invasive surgery (MIS) products and
techniques and integrated biologics solutions. The Company markets
its products and the products of its affiliates in the U.S. and in
over 50 countries internationally via a direct sales force and
independent distributors. Additional information can be found at
www.alphatecspine.com.
Forward Looking Statements
This press release may contain "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995 that involve risks and uncertainty. Such statements are
based on management's current expectations and are subject to a
number of risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. Alphatec Spine cautions investors that there can be no
assurance that actual results or business conditions will not
differ materially from those projected or suggested in such
forward-looking statements as a result of various factors. Forward
looking statements include references to the Company's commercial
strategy for its products, including those products noted in this
release. The words "believe," "will," "should," "expect," "intend,"
"estimate" and "anticipate," variations of such words and similar
expressions identify forward-looking statements, but their absence
does not mean that a statement is not a forward-looking
statement. The important factors that could cause actual
operating results to differ significantly from those expressed or
implied by such forward-looking statements include, but are not
limited to; the uncertainty of the commercial success of the
Alphatec Solus, Pegasus, ILLICO and Zodiac DVR systems ; the
uncertainty of success in licensing or developing and
commercializing new products or products currently in Alphatec
Spine's pipeline; failure to achieve acceptance of Alphatec Spine's
products by the surgeon community, including the Alphatec Solus,
Pegasus, ILLICO and Zodiac DVR systems ; failure to successfully
implement streamlining activities to create anticipated operational
savings; failure to successfully begin in-house manufacturing of
certain products; failure to obtain FDA clearance or approval for
new products, , or unexpected or prolonged delays in the process;
Alphatec Spine's ability to develop and expand its U.S. and/or
global revenues; continuation of favorable third party payor
reimbursement for procedures performed using Alphatec Spine's
products; unanticipated expenses or liabilities or other adverse
events affecting cash flow or Alphatec Spine's ability to
successfully control its costs or achieve profitability;
uncertainty of additional funding; Alphatec Spine's ability to
compete with other competing products and with emerging new
technologies; product liability exposure; failure to meet all
financial obligations in the Cross Medical Settlement or its credit
agreement; patent infringement claims and claims related to
Alphatec Spine's intellectual property or products sold by Alphatec
Spine. Please refer to the risks detailed from time to time in
Alphatec Spine's SEC reports, including its Annual Report Form 10-K
for the year ended December 31, 2012, filed on March 5, 2013 with
the Securities and Exchange Commission, as well as other filings on
Form 10-Q and periodic filings on Form 8-K. Alphatec Spine
disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise, unless required by law.
CONTACT: Investor/Media Contact:
Mark Francois
Senior Director, Investor Relations
Alphatec Spine, Inc.
(760) 494-6610
mfrancois@AlphatecSpine.com
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024